Enhanced Recovery After Surgery (ERAS) Protocols on Postoperative Outcomes in Patients Undergoing Major Abdominal Procedures
Impact of Enhanced Recovery After Surgery (ERAS) Protocols on Postoperative Outcomes in Patients Undergoing Major Abdominal Procedures
ERAS protocols are still only partially and unevenly implemented in many hospitals in developing nations, despite substantial worldwide evidence to the contrary. Because of institutional regulations, lack of understanding, or budget constraints, local surgical units frequently stick to traditional perioperative care approaches. Furthermore, there is a dearth of local data assessing the viability and efficacy of ERAS protocols in patients undergoing significant abdominal surgeries in our healthcare settings. Thus, the purpose of this study is to evaluate how ERAS protocols affect the postoperative results of patients having major abdominal surgery at our facility. The study's findings will be useful in determining whether ERAS pathways will assist our patient population heal more quickly, experience fewer issues, and spend less time in the hospital. The results might potentially encourage the use of standardized ERAS procedures in surgical practice, which would enhance patient care and maximize the use of medical resources
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Significant postoperative morbidity, extended hospital stays, delayed recovery, and higher healthcare expenditures are linked to major abdominal surgeries, including colorectal, hepatobiliary, and gastric procedures. Prolonged fasting, copious IV fluids, delayed mobilization, and delayed oral meals are common components of traditional perioperative care, which may raise physiological stress and hinder surgical recovery. Enhanced Recovery After Surgery (ERAS) guidelines have become a contemporary perioperative care strategy in recent years, with the goal of improving surgical outcomes and speeding recovery after major procedures.
In order to reduce surgical stress, maintain physiological function, and encourage early postoperative recovery, ERAS is a multidisciplinary, evidence-based treatment route that incorporates a number of perioperative techniques. Preoperative counseling, reduced fasting with carbohydrate loading, less invasive surgical procedures, multimodal analgesia, early mobilization, early oral feeding introduction, and other coordinated preoperative, intraoperative, and postoperative therapies are all part of these protocols. ERAS protocols have been extensively used in various surgical specialties over the last ten years, especially in colorectal and other significant abdominal procedures. When compared to traditional perioperative treatment, a number of recent research and systematic reviews have shown that ERAS approaches considerably improve postoperative outcomes. Without raising readmission or death rates, ERAS implementation has been linked to fewer postoperative complications, an earlier recovery of bowel function, a shorter hospital stay, and lower healthcare costs
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Muhammad Ali Armughan, MBBS
- Número de telefone: 03337950197
- E-mail: armughan915@gmail.com
Estude backup de contato
- Nome: mudassar saeed pansota, MS urology
- Número de telefone: 03223044443
- E-mail: netygeulis749@hotmail.com
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Patients of either gender between the ages of 18 and 70 years.
- Individuals having elective major abdominal surgery (such as small bowel resection, right hemicolectomy, left hemicolectomy, sigmoid colectomy, anterior resection, or similar colorectal resection).
- ASA class I-III patients
Exclusion Criteria:
- Patients who need to stay in the intensive care unit (ICU) after surgery for more than twenty-four hours.
- Individuals suffering from significant organ malfunction, such as advanced heart, liver, or kidney failure.
- Individuals who have had significant abdominal surgery within the recent three months.
- Patients who withdraw their consent or decline to participate in the study
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: ERAS
|
Patients managed by the surgical team according to the ERAS pathway will be included in Group A (ERAS group) |
|
Comparador de Placebo: Cuidado padrão
|
Patients managed according to routine conventional perioperative care during the study period will be included in Group B (conventional care group) |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Rate of Postoperative Complications
Prazo: 30 days
|
Surgical site infection: superficial, deep, or organ-space infection diagnosed clinically by the treating surgeon or supported by wound findings, culture results, imaging, or the need for antibiotics or drainage. Anastomotic leak: clinical or radiological evidence of leakage from a surgical anastomosis, including feculent discharge from drain or wound, intra-abdominal collection related to anastomosis, or leak confirmed on imaging or reoperation. Ileus: failure of return of bowel function requiring continued nil per oral status, nasogastric decompression, or delayed oral intake beyond routine postoperative recovery as documented by the surgical team). As recorded in the patient's medical file, complications will be found by radiological results, laboratory tests, and clinical examinations |
30 days
|
|
Mean hospital stay
Prazo: 1 week
|
described as the total number of days between the day of surgery and the day of hospital discharge. For every patient, it will be computed in days and documented |
1 week
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: muhammad ali armughan, MBBS, Allama Iqbal Teaching Hospital, DG Khan
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- Allama Iqbal Teaching Hospital
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .